Navigation Links
ALCAT Pioneer, Roger Deutsch, to Address "Food Allergies and Intolerances" at the Institute of Functional Medicine Conference in Tampa, February 8-10
Date:2/6/2013

DEERFIELD BEACH, Fla., Feb. 6, 2013 /PRNewswire/ -- Roger Deutsch, CEO of Cell Science Systems and pioneer of the ALCAT blood test, will be addressing the acclaimed Institute of Functional Medicine in Tampa Bay on Friday, February 8th.  The title of his presentation will be "Alternative Pathways in Life and Medicine".

The conference will be held at the Grand Hyatt Tampa Bay February 8-10th and the main topic will deal with Immunity and how dietary changes, lifestyle modifications, and nutraceutical, pharmaceutical, and botanical treatments can benefit the 23 million Americans sufferers of autoimmune diseases.

"I'm honored to attend such a prestigious event as many of the world's experts gather to discuss how environmental factors are playing a significant role in autoimmune diseases," said Roger Deutsch , CEO of Cell Science Systems and pioneer of the ALCAT blood test.  "I will specifically address in my presentation how food allergies and intolerances relate to autoimmune diseases."

ALCAT Worldwide is a division of Cell Science Systems, where the ALCAT Test is performed in its impressive licensed and FDA compliant laboratory.  The ALCAT Test is a simple blood test that measures the body's cellular response to a wide array of substances including foods, functional foods, medicinal herbs, food additives, food colorings, environmental chemicals, molds, pharmacoactive agents, and antibiotics.  The ALCAT Test identifies the personal triggers of inflammation caused by foods and chemicals.

The main objective of The Institute for Functional Medicine is to reverse today's epidemic of chronic disease through education, research, and collaboration. www.functionalmedicine.org

Cell Science Systems, Corp. (CSS), located in Deerfield Beach, Florida, is a life sciences company and the worldwide market leader in food sensitivity testing as the manufacturer of the ALCAT Test. CSS operates a State of Florida and US government (CLIA) licensed laboratory; as well as an FDA registered, ISO certified, cGMP, medical device manufacturing facility. Available for over 25 years, the ALCAT Test identifies cellular reactions to over 350 foods, chemicals and herbs. These inflammatory reactions are linked to chronic health problems like obesity and diabetes, as well as skin, heart, joint, and digestive disorders.  To find out more about the ALCAT test please visit: http://www.alcat.com.   

Media Contact:
Glen Calder , TransMedia Group 561-750-9800 ext. 216 gcalder@transmediagroup.com


'/>"/>
SOURCE Cell Science Systems, Corp.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Imaging Contract-Research Pioneer, Donald P. Rosen, MD, Named CEO of ACR Image Metrix™
2. Genomatica, Inc., Award-Winning Industrial Biotechnology Pioneer, Selects Alexandria Real Estate Equities, Inc. for Long-Term, Mission-Critical R&D Facility and Corporate Headquarters
3. The Law Office of Roger G. Worthington, P.C. - Longtime Supporter of the Pacific Meso Center - Donates $100,000 for Mesothelioma Research
4. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
5. Unigenes 2011 Year in Review - Key Elements in Place to Address Debt in 2012
6. Music Legend And Health Advocate Bret Michaels To Address Diversity Alliance For Science 2012 National Conference And EXPO
7. CEM President and CEO Delivers Commencement Address at the 2012 University of Texas at Austin Chemistry and Biochemistry Department Graduation
8. Biodetection 2012 Conference Brings Together Leading Organizations from Around the World to Address Challenges & Technology Advances in Detection and Identification of Biological Threats in Washington, DC from June 28-29, 2012
9. Specialty Chemical Forum 2012 Kicks Off in Houston; AkzoNobels Frank Sherman Delivers Keynote Address
10. Sequenom Addresses Preliminary Injunction Decision, Reaffirms Defense of Patent
11. Addressing the need for microscopic speed
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... The Board of ... appointment of John Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from ... founding commercial leaders responsible for the commercialization of multiple orphan drug indications. ...
(Date:4/27/2016)... ... ... Global Stem Cells Group CEO Benito Novas announced that Duncan Ross, Ph.D. ... Labs in Miami. , In 2004, Ross received his Ph.D. in Immunology from the ... the suppression of graft vs. host disease (GVHD) under UM Professor Robert Levy Ph.D. ...
(Date:4/26/2016)... ... April 27, 2016 , ... ... Roca Rothgerber Christie LLP as an associate in the firm’s Intellectual Property practice ... electrical, mechanical and electromechanical patent applications. He has an electrical engineering and computer ...
(Date:4/26/2016)... ... April 26, 2016 , ... Mr. Palmer created the RPO ... the first multi-million dollar, multi-year managed services contract in the U.S. intelligence community with ... our leadership team,” said John Younger, founder of Accolo. “We are growing and ...
Breaking Biology Technology:
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
Breaking Biology News(10 mins):